ArticleBMC ophthalmology2026
Pediatric conjunctival papilloma managed with staged multimodal therapy: a case report.
Article in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundConjunctival papilloma is a rare benign ocular surface tumor in children, most commonly associated with low-risk human papillomavirus types 6 and 11. Management can be challenging because of multifocal disease, persistence, recurrence, and the need to preserve healthy conjunctival tissue in young patients. We report a pediatric case of multifocal conjunctival papilloma successfully managed with a staged multimodal approach combining preoperative medical therapy with limited surgical excision. CASE PRESENTATION: A 4-year-old boy presented with multifocal conjunctival papillomatous lesions. Following clinical evaluation and diagnosis of conjunctival papilloma, preoperative topical and intralesional interferon alfa-2b were administered to reduce the lesion size. Residual lesions were subsequently treated with limited surgical excision following preoperative interferon-mediated debulking and intraoperative application of mitomycin C. The patient had a favorable clinical course, with preservation and progressive restoration of the conjunctival architecture. At 2 years of follow-up, there was no evidence of recurrence.
conclusionsThis case highlights the potential value of a staged multimodal strategy for managing multifocal conjunctival papilloma in children. Preoperative medical debulking followed by targeted surgical excision may help reduce the extent of surgery, preserve healthy conjunctival tissue, and achieve durable disease control. This approach may be particularly useful in pediatric ocular surface disease, where tissue preservation is an important consideration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.